Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue microarrays for high-throughput molecular pathology.

Khawla Al Kuraya1, Ronald Simon, Guido Sauter

  • 1King Faisal Hospital and Research Center, Riyadh, Saudi Arabia.

Annals of Saudi Medicine
|August 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes.

Annals of surgical oncology·2022
Same author

Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.

Experimental and molecular pathology·2022
Same author

Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors.

Neuroendocrinology·2022
Same author

VPRBP Functions Downstream of the Androgen Receptor and OGT to Restrict p53 Activation in Prostate Cancer.

Molecular cancer research : MCR·2022
Same author

PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power.

Cancers·2022
Same author

Combination of Biochemical and Cytological Findings for Better Diagnosis in Pleural Effusions.

Advances in experimental medicine and biology·2022

Tissue microarray (TMA) technology enables simultaneous analysis of numerous tissue samples, overcoming limitations of traditional methods. This accelerates molecular disease classification, drug development, and personalized treatment prediction.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cancer Research

Background:

  • Microarray technologies (DNA, protein, antibody) identify molecular markers for disease classification and treatment prediction.
  • Validating these markers requires large-scale human tissue analysis, which is a bottleneck due to slow, expensive conventional methods.

Purpose of the Study:

  • To introduce tissue microarray (TMA) technology as a solution to the limitations of conventional tissue analysis.
  • To highlight the potential of TMA in accelerating molecular research and its translation to clinical practice.

Main Methods:

  • Tissue microarray (TMA) technology allows simultaneous analysis of up to 1,000 tissue samples.
  • TMA is compatible with various in-situ analyses, including immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and RNA in situ hybridization (RNA-ISH).

Related Experiment Videos

Main Results:

  • TMA significantly enhances the speed and efficiency of large-scale tissue analysis compared to slide-by-slide methods.
  • TMA facilitates the simultaneous examination of numerous samples, reducing costs and time.

Conclusions:

  • TMA technology overcomes critical bottlenecks in molecular discovery and validation.
  • TMA has broad applications in establishing molecular-clinical associations, testing therapeutic targets, standardizing molecular detection, and translating research findings.
  • TMA's economic benefits and ability to reveal ethnic differences in tumor biology make it valuable, especially for developing countries.